|
CellCentric is focused on epigenetics – those modifications
and mechanisms that sit on top of DNA and influence cellular
control and cell fate. This is an emerging area of science
that has great potential as a source of novel therapeutic
approaches for multiple intractable diseases, including cancer.
However much of the scientific understanding of epigenetics
is early and fragmented.
CellCentric addresses this by having exclusive relationships
with over 20 of the world’s leading laboratories working
in epigenetics across three continents. The company is able
to help identify, select and patent the best opportunities
for commercial development.
CellCentric continues to build and manage a portfolio of
the most competitive targets, screens and hits in epigenetics,
making them ready for full scale pharmaceutical development.
|
